TrialJournal of the American Heart Association2019

Relationship Between Low-Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab.

Michael D Shapiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.